Tranexamic acid 1197-18-8 Hemostasis Fatty acid
Payment: T/T, L/C
Product Origin: China
Shipping Port: Beijing/Shanghai/Hangzhou
Production capacity: 1200kg/month
Order(MOQ): 25kg
Lead Time: 3 Working Days
Storage condition: Stored in cool, dry place, room temperature.
Package material: drum
Package size: 25kg/drum
Safety information: Not dangerous goods
Introduction
Tranexamic acid (TXA) is a medication used to treat or prevent excessive blood loss from major trauma, postpartum bleeding, surgery, tooth removal, nosebleeds, and heavy menstruation.
In hereditary hemorrhagic telangiectasia - Tranexamic acid has been shown to reduce frequency of epistaxis in patients suffering severe and frequent nosebleed episodes from hereditary hemorrhagic telangiectasia.
In melasma - tranexamic acid is sometimes used in skin whitening as a topical agent, injected into a lesion, or taken by mouth, both alone and as an adjunct to laser therapy; as of 2017 its safety seemed reasonable but its efficacy for this purpose was uncertain because there had been no large scale randomized controlled studies nor long term follow-up studies.
In hyphema - Tranexamic acid has been shown to be effective in reducing risk of secondary hemorrhage outcomes in people with traumatic hyphema.
Specification (BP2020)
|
Item |
Specification |
| Appearance | White or almost white crystalline powder |
| Identification | Infrared absorption spectrophotometry |
| Solubility | Free soluble in water and in glacial acetic acid, practically insoluble in acetone and 96% alcohol |
| Clarity and color | Solution should clarify and colorless |
| PH | 7.0~8.0 |
| Related substances liquid chromatography | Impurity A ≤0.1% |
| Impurity B ≤0.15% | |
| Impurity C ≤0.05% | |
| Impurity D ≤0.05% | |
| Impurity E ≤0.05% | |
| Impurity F ≤0.05% | |
| Unspecified impurities, for each impurity ≤0.05% | |
| Loss on drying | ≤0.5% |
| Sulphated ash | ≤0.1% |
| Heavy metals | ≤10ppm |
| Chlorides | ≤140ppm |
| Assay (Dried substance) | 99.0%~101.0% |
